GW & Wade’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $10.2M | Sell |
354,188
-49,968
| -12% | -$1.51M | 0.33% | 73 |
|
|
2023
Q3 | $13.4M | Sell |
404,156
-43,444
| -10% | -$1.54M | 0.5% | 59 |
|
|
2023
Q2 | $16.4M | Buy |
447,600
+6,258
| +1% | +$244K | 0.6% | 53 |
|
|
2023
Q1 | $18M | Buy |
441,342
+6,176
| +1% | +$267K | 0.69% | 46 |
|
|
2022
Q4 | $22.3M | Buy |
435,166
+6,801
| +2% | +$326K | 0.91% | 31 |
|
|
2022
Q3 | $18.7M | Buy |
428,365
+6,004
| +1% | +$292K | 0.92% | 30 |
|
|
2022
Q2 | $22.1M | Buy |
422,361
+10,926
| +3% | +$557K | 1% | 23 |
|
|
2022
Q1 | $21.3M | Buy |
411,435
+4,182
| +1% | +$217K | 0.91% | 29 |
|
|
2021
Q4 | $24M | Buy |
407,253
+2,010
| +0.5% | +$99.6K | 1.04% | 28 |
|
|
2021
Q3 | $17.4M | Buy |
405,243
+3,337
| +0.8% | +$148K | 0.83% | 38 |
|
|
2021
Q2 | $15.7M | Buy |
401,906
+7,777
| +2% | +$302K | 0.76% | 44 |
|
|
2021
Q1 | $14.3M | Buy |
394,129
+57,588
| +17% | +$2.04M | 0.76% | 44 |
|
|
2020
Q4 | $12.4M | Buy |
336,541
+11,550
| +4% | +$424K | 0.75% | 47 |
|
|
2020
Q3 | $11.3M | Buy |
324,991
+26,220
| +9% | +$919K | 0.86% | 39 |
|
|
2020
Q2 | $9.27M | Buy |
298,771
+6,228
| +2% | +$212K | 0.76% | 45 |
|
|
2020
Q1 | $9.06M | Sell |
292,543
-1,447
| -0.5% | -$49.3K | 0.85% | 41 |
|
|
2019
Q4 | $10.9M | Sell |
293,990
-29,876
| -9% | -$1.06M | 0.84% | 40 |
|
|
2019
Q3 | $11M | Buy |
323,866
+7,141
| +2% | +$260K | 0.94% | 36 |
|
|
2019
Q2 | $13M | Buy |
316,725
+256,204
| +423% | +$10.2M | 1.18% | 24 |
|
|
2019
Q1 | $2.44M | Buy |
60,521
+1,094
| +2% | +$43.8K | 0.23% | 79 |
|
|
2018
Q4 | $2.46M | Sell |
59,427
-773
| -1% | -$32.1K | 0.27% | 76 |
|
|
2018
Q3 | $2.52M | Sell |
60,200
-4,746
| -7% | -$183K | 0.27% | 75 |
|
|
2018
Q2 | $2.24M | Sell |
64,946
-1,871
| -3% | -$63.9K | 0.25% | 77 |
|
|
2018
Q1 | $2.25M | Buy |
66,817
+20,620
| +45% | +$709K | 0.26% | 76 |
|
|
2017
Q4 | $1.59M | Sell |
46,197
-10,721
| -19% | -$366K | 0.18% | 91 |
|
|
2017
Q3 | $1.93M | Sell |
56,918
-2,126
| -4% | -$68.3K | 0.23% | 77 |
|
|
2017
Q2 | $1.88M | Sell |
59,044
-383
| -0.6% | -$12.1K | 0.24% | 75 |
|
|
2017
Q1 | $1.93M | Buy |
59,427
+859
| +1% | +$27.1K | 0.25% | 71 |
|
|
2016
Q4 | $1.8M | Sell |
58,568
-412
| -0.7% | -$12.6K | 0.3% | 66 |
|
|
2016
Q3 | $1.9M | Buy |
58,980
+633
| +1% | +$21.2K | 0.34% | 60 |
|
|
2016
Q2 | $1.95M | Buy |
58,347
+532
| +0.9% | +$17K | 0.33% | 70 |
|
|
2016
Q1 | $1.63M | Sell |
57,815
-5,014
| -8% | -$143K | 0.32% | 63 |
|
|
2015
Q4 | $1.92M | Buy |
62,829
+4,773
| +8% | +$150K | 0.4% | 57 |
|
|
2015
Q3 | $1.73M | Buy |
58,056
+4,020
| +7% | +$129K | 0.38% | 62 |
|
|
2015
Q2 | $1.72M | Buy |
54,036
+4,778
| +10% | +$156K | 0.34% | 67 |
|
|
2015
Q1 | $1.63M | Buy |
+49,258
| New | +$1.57M | 0.31% | 72 |
|
Other funds holding PFE
GW & Wade's PFE Position: Q4 2023 in Review
GW & Wade reduced its Pfizer (PFE) stake by 12% in Q4 2023, selling an estimated $1.51M and leaving 354,188 shares worth $10.2M. The position accounts for 0.33% of the portfolio, ranked #73.
GW & Wade first reported a position in PFE in Q1 2015 and has held it in 36 quarters since. The position peaked at $24M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- GW & Wade held 354,188 shares of Pfizer worth $10.2M as of Q4 2023.
- GW & Wade sold 49,968 Pfizer shares in Q4 2023, an estimated $1.51M.
- Pfizer made up 0.33% of GW & Wade's portfolio in Q4 2023, its #73 holding.
- GW & Wade first reported a position in Pfizer in Q1 2015 and has held it in 36 quarters since.
- GW & Wade's Pfizer position peaked at $24M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.